CRVS
Corvus Pharmaceuticals, Inc.Closed9.41−0.64 −6.37%USD
NasdaqGM · as of Oct 13, 16:00 ET · 15m delayAfter hours 9.41 0.00%
Open
9.99
Prev close
10.05
Day range
9.3210.03
52-week range
6.3926.95
Volume
1.69M1.75×
Mkt cap
791.58M
P/E ttm
—
Fwd P/E
-8.81
EPS ttm
-0.6200
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−65.08%
CRVS earnings and estimates
CRVS Next Report
Yahoo Finance · Nasdaq
Report date
Tue, Nov 3
After the close
EPS consensus
$−0.20
range −0.22 – −0.18
EPS growth vs year ago
−70.8%
year ago −0.12
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±27.1%
by Nov 20 · ATM straddle
Past 4 reactions
±3.2%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 AMC | −0.19 | −0.17 | −13.43% | $0 | +0.4% | +9.2% |
| Mar '26 | May 7, 2026 AMC | −0.15 | −0.15 | +2.17% | $0 | +6.6% | −6.4% |
| Dec '25 | Mar 12, 2026 AMC | −0.15 | −0.13 | −13.21% | $0 | −4.3% | −12.0% |
| Sep '25 | Nov 4, 2025 AMC | −0.12 | −0.14 | +11.11% | $0 | −1.4% | +6.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.20 | −0.22−0.18 | −70.8% | $0 | 0.0% | −0.20 0.0% | −0.19 −7.9% | 0 / 3 |
| Next quarter Dec 2026 | −0.23 | −0.25−0.18 | −51.7% | $0 | 0.0% | −0.23 0.0% | −0.21 −8.3% | 0 / 3 |
| Current year Dec 2026 | −0.78 | −0.81−0.71 | −44.7% | $0 | 0.0% | −0.78 0.0% | −0.72 −8.5% | 0 / 3 |
| Next year Dec 2027 | −1.07 | −1.28−0.83 | −37.3% | $4.55M | 0.0% | −1.07 0.0% | −0.95 −12.8% | 0 / 3 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.21 | −0.23−0.18 | 2 | 0 / 0 |
| Dec 2026 | −0.21 | −0.23−0.18 | 2 | 0 / 0 |
| Mar 2027 | −0.22 | −0.23−0.21 | 2 | 0 / 0 |
| Jun 2027 | −0.23 | −0.24−0.22 | 2 | 0 / 0 |
| Sep 2027 | −0.21 | −0.23−0.18 | 2 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.79 | −0.83−0.71 | 5 | 0 / 0 |
| Dec 2027 | −1.06 | −1.28−0.80 | 4 | 0 / 0 |
| Dec 2028 | −0.56 | −0.76−0.37 | 2 | 0 / 0 |
| Dec 2029 | −0.02 | −0.03−0.01 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.